Factors associated with patient and graft survival using kidneys from cadaveric donors in transplanted patients over 18 years of age in Argentina
Background: With improvements in short-term kidney graft and patient survival, focus has shifted to understand patient and graft features that affect long-term survival. Materials and methods: This retrospective analysis from January 1998 to December 2009 employed Kaplan-Meier analysis to evaluate s...
Guardado en:
| Autor principal: | |
|---|---|
| Otros Autores: | , , , |
| Formato: | Capítulo de libro |
| Lenguaje: | Inglés |
| Publicado: |
Elsevier USA
2012
|
| Materias: | |
| Acceso en línea: | Registro en Scopus DOI Handle Registro en la Biblioteca Digital |
| Aporte de: | Registro referencial: Solicitar el recurso aquí |
| LEADER | 07155caa a22008177a 4500 | ||
|---|---|---|---|
| 001 | PAPER-23516 | ||
| 003 | AR-BaUEN | ||
| 005 | 20230518205513.0 | ||
| 008 | 190411s2012 xx ||||fo|||| 00| 0 eng|d | ||
| 024 | 7 | |2 scopus |a 2-s2.0-84866329017 | |
| 040 | |a Scopus |b spa |c AR-BaUEN |d AR-BaUEN | ||
| 030 | |a TRPPA | ||
| 100 | 1 | |a Bisigniano, L. | |
| 245 | 1 | 0 | |a Factors associated with patient and graft survival using kidneys from cadaveric donors in transplanted patients over 18 years of age in Argentina |
| 260 | |b Elsevier USA |c 2012 | ||
| 270 | 1 | 0 | |m Bisigniano, L.; Scientific-Technical Office at INCUCAI, Ramsay 2250, CP 1428, Ciudad de Buenos Aires, Argentina; email: lbisingiano@incucai.gov.ar |
| 506 | |2 openaire |e Política editorial | ||
| 504 | |a Wolfe, R.A., Ashby, V.B., Milford, E.L., Comparison of mortality in all patients on dialysis, patients on dialysis awaitin trasplantation, and recipients of a first cadaveric transplant (1999) N Engl J Med, 341, p. 1725 | ||
| 504 | |a Laupacis, A., Keown, P., Pus, N., A study of the quality of life and cost-utility of renal transplantation (1996) Kidney Int, 50, p. 235 | ||
| 504 | |a Hariharan, S., Johnson, C.P., Bresnahan, B., Improved graft survival after renal transplantation in the United States, 1988 to 1996 (2000) N Eng J Med, 342, p. 605 | ||
| 504 | |a Hariharan, S., McBride, M.A., Bennet, L.E., Risk factors for renal allograft survival from older cadaveric donors (1997) Transplantation, 64, p. 1748 | ||
| 504 | |a Sollinger, H.W., Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients (1995) Transplantation, 60, p. 225 | ||
| 504 | |a Pirsch, J.D., Miller, J., Deirerhoi, M.H., A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation (1997) Transplantation, 63, p. 977 | ||
| 504 | |a Roberts, J.P., Wolfe, R.A., Effect of changing the priority for HLA matching on the rates and outcomes of kidney transplantation in minority groups (2004) N Engl J Med, 350, p. 545 | ||
| 504 | |a Opelz, G., Dohler, B., Effect of HLA compatibility on kidney graft survival: Comparative analysis of two decades (2007) Transplantation, 84, p. 137 | ||
| 504 | |a Hume, D.M., Merrill, J.P., Miller, B.F., Experiences with renal homotransplantation in the human: Report of nine cases (1955) J Clin Invest, 34, p. 327 | ||
| 504 | |a Merion, R.M., White, D.J.G., Thiru, S., Cyclosporine: Five years experience in cadaveric renal transplantation (1984) N Engl J Med, 310, p. 148 | ||
| 520 | 3 | |a Background: With improvements in short-term kidney graft and patient survival, focus has shifted to understand patient and graft features that affect long-term survival. Materials and methods: This retrospective analysis from January 1998 to December 2009 employed Kaplan-Meier analysis to evaluate survival ratios at 30 days as well as 1, 5, and 10 years. A multivariable Cox regression model considered variables of donor and recipient, gender and age, cold ischemia time (CIT), chronic renal failure etiology, time on dialysis (TD) and cause of donor death. The mismatch (MM) value was coded according to the number of antigens shared by both the donor and the recipient for HLA-A, B, and DR. The MM values ranged between 0 and 6. Two groups were analyzed according the number of shared antigens: 0 to 3 versus 4 to 6. Results: Among 3030 (55.85%) males and 2395 (44.15%) females, the overall mean age was 46.9 ± 13.9 years. Median follow-up was 4 years (max 13 years). Patient survival rate (SR) was 97.5% at 30 days, 87.5% at 1 year, 74.5% at 5 years, and 59.2% at 10 years. Using Cox analysis, patient SR was affected by: diabetic nephropathy (DN) hazard ratio (HR) 1.55 (95% confidence interval [CI 95%] 1.21-1.97) P =.0005; head trauma (HT) cause of donor death HR 0.83 (0.73-0.95) P =.0005 and donor age (DA) compared by 18 to 44 years: 45 to 59 years HR 1.44 (CI95% 1.00-1.30) P =.043, >60 years HR 1.41 (CI95% 1.17-1.70) P =.0004. In addition relevant factors were recipient age (RA) compared by 18 to 44 years: 45 to 59 HR 1.99 (CI95% 1.74-2.27) P <.0001, >60 years HR 3.24 (CI95% 2.79-3.75) P <.0001 and DT >7 years HR 1.33 (CI95% 1.19-1.48) P =.0001. MM HLA 0 to 3 level HR 0.78 (CI95% 0.69-0.88) P <.0001. Graft SR was 95% at 30 days, 81.6% at 1 year, 64.7% at 5 years, and 47.3% at 10 years. The relevant factors were: DN HR 1.26 (CI95% 1.01-1.57) P =.04; HT HR 0.82 (0.74-0.91) P =.0004; DA compared by 18 to 44 years: 45-59 years HR 1.19 (CI95% 1.07-1.32) P =.002, >60 years HR 1.53 (CI95% 1.30-1.80) P <.0001; RA compared by 18 to 44 years: 45-59 HR 1.33 (CI95% 1.19-1.47) P <.0001, >60 years HR 1.84 (CI95% 1.63-2.09) P <.0001; DT > 7 years HR 1.22 (CI95% 1.11-1.35) P =.0001; CIT >24 hours HR 1.13 (CI95% 1.03-1.23) P =.009 and MM HLA 0 to 3 HR 0.82 (CI95% 0.74-0.91) P =.0002. Conclusion: HT as the cause of donor death and MM between 0 and 3 were associated with better patient and graft SR, DN, TD over 7 years, DA and RA over 45 were associated with lower patient SR. CIT > 24 hours, DN, TD over 7 years, as well as donor and recipient ages over 45 yr were associated with a lower graft SR. © 2012 Published by Elsevier Inc. |l eng | |
| 593 | |a Scientific-Technical Office at INCUCAI, Ramsay 2250, CP 1428, Ciudad de Buenos Aires, Argentina | ||
| 690 | 1 | 0 | |a ANTIGEN |
| 690 | 1 | 0 | |a ADOLESCENT |
| 690 | 1 | 0 | |a ADULT |
| 690 | 1 | 0 | |a ANOXIA |
| 690 | 1 | 0 | |a CADAVER KIDNEY |
| 690 | 1 | 0 | |a CAUSE OF DEATH |
| 690 | 1 | 0 | |a CHILD |
| 690 | 1 | 0 | |a CHRONIC KIDNEY FAILURE |
| 690 | 1 | 0 | |a COMA |
| 690 | 1 | 0 | |a CONFERENCE PAPER |
| 690 | 1 | 0 | |a CONTROLLED STUDY |
| 690 | 1 | 0 | |a DATA ANALYSIS SOFTWARE |
| 690 | 1 | 0 | |a DIALYSIS |
| 690 | 1 | 0 | |a FEMALE |
| 690 | 1 | 0 | |a GRAFT SURVIVAL |
| 690 | 1 | 0 | |a HEAD INJURY |
| 690 | 1 | 0 | |a HLA SYSTEM |
| 690 | 1 | 0 | |a HUMAN |
| 690 | 1 | 0 | |a KIDNEY TRANSPLANTATION |
| 690 | 1 | 0 | |a MALE |
| 690 | 1 | 0 | |a MISMATCH NEGATIVITY |
| 690 | 1 | 0 | |a PRIORITY JOURNAL |
| 690 | 1 | 0 | |a PROPORTIONAL HAZARDS MODEL |
| 690 | 1 | 0 | |a SCHOOL CHILD |
| 690 | 1 | 0 | |a SEX DIFFERENCE |
| 690 | 1 | 0 | |a STROKE |
| 690 | 1 | 0 | |a SURVIVAL RATE |
| 690 | 1 | 0 | |a SURVIVAL TIME |
| 690 | 1 | 0 | |a TUMOR |
| 651 | 4 | |a ARGENTINA | |
| 700 | 1 | |a López-Rivera, A. | |
| 700 | 1 | |a Tagliafichi, V. | |
| 700 | 1 | |a Fernández, V. | |
| 700 | 1 | |a Soratti, C. | |
| 773 | 0 | |d Elsevier USA, 2012 |g v. 44 |h pp. 2235-2238 |k n. 7 |p Transplant. Proc. |x 00411345 |w (AR-BaUEN)CENRE-7067 |t Transplantation Proceedings | |
| 856 | 4 | 1 | |u https://www.scopus.com/inward/record.uri?eid=2-s2.0-84866329017&doi=10.1016%2fj.transproceed.2012.07.127&partnerID=40&md5=790d800d3e63afcc83562ee59cd9ac26 |y Registro en Scopus |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.transproceed.2012.07.127 |y DOI |
| 856 | 4 | 0 | |u https://hdl.handle.net/20.500.12110/paper_00411345_v44_n7_p2235_Bisigniano |y Handle |
| 856 | 4 | 0 | |u https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_00411345_v44_n7_p2235_Bisigniano |y Registro en la Biblioteca Digital |
| 961 | |a paper_00411345_v44_n7_p2235_Bisigniano |b paper |c PE | ||
| 962 | |a info:eu-repo/semantics/article |a info:ar-repo/semantics/artículo |b info:eu-repo/semantics/publishedVersion | ||
| 999 | |c 84469 | ||